Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

That “newsletter” is a tad out of date:

“ The company said last week that it was expecting results for its Phase 2 clinical trial of Brilacidin to be revealed on November 8. The study data is presently blinded at the data management vendor, with final checks and approvals in progress.”

It also recommends NWBO which is undoubtedly a scam.

And don’t forget the disclaimer:

“We are engaged in the business of marketing and advertising companies for monetary compensation.”

https://insiderfinancial.com/disclaimer/

When OTC companies like IPIX pay junk newsletters like Insider Financial to publish ludicrous and inaccurate hype that’s invariably a huge red flag.